Abstract:Oxidative stress reflects an imbalance between the overproduction and incorporation of free radicals and the dynamic ability of a biosystem to detoxify reactive intermediates. Free radicals produced by oxidative stress are one of the common features in several experimental models of diseases. Free radicals affect both the structure and function of neural cells, and contribute to a wide range of neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Although the precise mechanisms that result in the degeneration of neurons and the relevant pathological changes remain unclear, the crucial role of oxidative stress in the pathogenesis of neurodegenerative diseases is associated with several proteins (such as α-synuclein, DJ-1, Amyloid β and tau protein) and some signaling pathways (such as extracellular regulated protein kinases, phosphoinositide 3-kinase/Protein Kinase B pathway and extracellular signal-regulated kinases 1/2) that are tightly associated with the neural damage. In this review, we present evidence, gathered over the last decade, concerning a variety of pathogenic proteins, their important signaling pathways and pathogenic mechanisms associated with oxidative stress in Parkinson's disease and Alzheimer's disease. Proper control and regulation of these proteins' functions and the related signaling pathways may be a promising therapeutic approach to the patients. We also emphasizes antioxidative options, including some new neuroprotective agents that eliminate excess reactive oxygen species efficiently and have a certain therapeutic effect; however, controversy surrounds some of them in terms of the dose and length of therapy. These agents require further investigation by clinical application in patients suffering Parkinson's disease and Alzheimer's disease.

The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases

Emerging Clues of Regulatory Roles of Circular RNAs Through Modulating Oxidative Stress: Focus on Neurological and Vascular Diseases.

Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases

Microglial Exosomes in Neurodegenerative Disease

Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer's Disease Pathology and Diagnosis

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer's Disease

Present and future use of exosomes containing proteins and RNAs in neurodegenerative diseases for synaptic function regulation: A comprehensive review

Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease

The role of exosomal microRNAs in central nervous system diseases

Pathophysiology of Ischemic Stroke: Noncoding RNA Role in Oxidative Stress

Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases

Exosomes: the endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders

Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications

The Emerging Role of Neural Cell-Derived Exosomes in Intercellular Communication in Health and Neurodegenerative Diseases

Exosomes, an Unmasked Culprit in Neurodegenerative Diseases